You searched for - Page 58 of 142 - KFF Health News

Money-Saving Offer For Medicare’s Late Enrollees Is Expiring. Can They Buy Time?

By Susan Jaffe September 22, 2017 KFF Health News Original

Sept. 30 marks the end of Medicare’s temporary offer to waive penalties for certain late Medicare enrollees with Affordable Care Act insurance coverage.

10 Ways Medicaid Affects Us All

October 5, 2017 KFF Health News Original

Medicaid was created in 1965 as a program for the poor. Today, it helps 74 million people — more than 1 of every 5 people in the U.S. You or someone you know likely benefits.

Celgene Expected To Rake In $15B This Year With Strength Of Its Blockbuster Cancer Drug

July 27, 2018 Morning Briefing

But the company is on the look-out for its next blockbuster as Revlimid will face market competition in coming years. Meanwhile, advocate groups ask for insurance commissioners will investigate the growing use of copay accumulators.

Defending Against This Season’s Deadly Flu: 5 Things To Know Now

By Barbara Feder Ostrov January 9, 2018 KFF Health News Original

A particularly nasty flu is widespread in 46 states. Nationally, at least 106 people have died from the infectious disease.

Bill Of The Month: For Toenail Fungus, A $1,500 Prescription

By Shefali Luthra March 16, 2018 KFF Health News Original

How a prescription wiped out one woman’s health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don’t) with medical costs.

Facebook Live: It’s ACA Sign Up Season. Here’s What you Need To Know This Year.

November 2, 2017 KFF Health News Original

In this Facebook Live chat, KHN’s Julie Appleby answers questions about what’s changed for 2018 open enrollment.

Heart Device Failure: Medicare Spent $1.5B Over 10 Years To Replace Defective Implants

By Fred Schulte and Christina Jewett October 2, 2017 KFF Health News Original

The inspector general at Health and Human Services says defective pacemakers or defibrillators had to be replaced from 2005 through 2014, costing Medicare $1.5 billion.

Tending To Patients As Her New Home Burns

By April Dembosky, KQED October 16, 2017 KFF Health News Original

ICU nurse Julayne Smithson had only a few minutes to grab some things from her recently purchased home a block from the Santa Rosa hospital. Then she rushed back to help evacuate patients and has scarcely stopped working since.

Appeals Court Delivers Latest Blow To Hospitals By Rejecting Challenge To 340B Changes

July 18, 2018 Morning Briefing

The program helps hospitals cover charity costs related to prescriptions drugs. Last July, the Trump administration proposed slashing its higher reimbursement for the drugs by about 27 percent. A judge ruled that the hospitals had challenged the changes prematurely as none of them had taken effect yet, and the court of appeals on Tuesday affirmed the decision.

States Strive To Curb Costs For A Crucial — But Exorbitant — Hemophilia Treatment

By Barbara Feder Ostrov Photos by Heidi de Marco March 6, 2018 KFF Health News Original

Saving the lives of people with the bleeding disorder can require high doses of expensive blood-clotting factor. Taxpayers foot much of the bill as manufacturers profit enormously.

Medicare’s Financial Outlook Slightly Improved, Trustees Say

By Phil Galewitz July 13, 2017 KFF Health News Original

The assessment pushes back the date for the hospital insurance trust fund to go bankrupt by one year. It also says Part B premiums next year will be stable.

Azar Warns Pharma That Administration Will Be ‘Turning On The Pressure’ As He Defends President’s Drug Plan

May 15, 2018 Morning Briefing

HHS Secretary Alex Azar blasted a long-standing Democratic idea for Medicare to negotiate drug prices, saying it would deny access to medicines “through rationing or setting prices,” which he called a “move toward socialized medicine.” However, Azar did promise to upend Medicare Part B’s payment structure.

Massachusetts Grabs Spotlight By Proposing New Twist On Medicaid Drug Coverage

By Shefali Luthra November 21, 2017 KFF Health News Original

In an effort to reduce drug costs and increase efficiency, Massachusetts is seeking federal approval to implement a new approach to how the state’s Medicaid program covers prescription medications.

So Much Care It Hurts: Unneeded Scans, Therapy, Surgery Only Add To Patients’ Ills

By Liz Szabo October 23, 2017 KFF Health News Original

Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.

Perspectives: Administration’s Proposition On 340B Drug Program Is Equivalent Of An Own-Goal In Soccer

July 11, 2018 Morning Briefing

Read recent commentaries about drug-cost issues.

Facebook Live: Things To Know About Trump’s Directive On Health Insurance

October 12, 2017 KFF Health News Original

In this Facebook Live, KHN’s Julie Appleby answers questions about President Donald Trump’s executive order regarding insurance.

Frail Patients Losing Access To Dental House Calls

By Ana B. Ibarra Photos by Heidi de Marco January 2, 2018 KFF Health News Original

Dental hygienists who treat frail and elderly residents in nursing homes and other facilities are dropping out of California’s publicly funded dental program for the poor because of recent changes that cut their pay and create more administrative hurdles.

Podcast: ‘What The Health?’ Meanwhile, In Other Health News…

November 21, 2017 KFF Health News Original

In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Sarah Jane Tribble of Kaiser Health News discuss some of the under-covered health stories of the past several weeks, including drug price issues, the opioid epidemic and women’s reproductive health.

Of ‘Miracles’ And Money: Why Hemophilia Drugs Are So Expensive

By Jenny Gold Photos by Heidi de Marco March 8, 2018 KFF Health News Original

The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn’t worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.

Cities, Counties and Schools Sidestep FDA Canadian Drug Crackdown, Saving Millions

By Phil Galewitz December 8, 2017 KFF Health News Original

Medicines are up to 80 percent cheaper north of the border and overseas, so U.S. localities are greasing a pharmaceutical pipeline that the feds warn is illegal and possibly unsafe.

Filter Results

More From KFF Health News